FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311651314> ?p ?o ?g. }

• W4311651314 endingPage "e0278928" @default.
• W4311651314 startingPage "e0278928" @default.
• W4311651314 abstract "Background The amplification of GTP cyclohydrolase 1 ( pfgch1 ) in Plasmodium falciparum has been linked to the upregulation of the pfdhfr and pfdhps genes associated with resistance to the antimalarial drug sulfadoxine-pyrimethamine. During the 1990s and 2000s, sulfadoxine-pyrimethamine was withdrawn from use as first-line treatment in southeast Asia due to clinical drug resistance. This study assessed the temporal and geographic changes in the prevalence of pfdhfr and pfdhps gene mutations and pfgch1 amplification a decade after sulfadoxine-pyrimethamine had no longer been widely used. Methods A total of 536 P . falciparum isolates collected from clinical trials in Thailand, Cambodia, and Lao PDR between 2008 and 2018 were assayed. Single nucleotide polymorphisms of the pfdhfr and pfdhps genes were analyzed using nested PCR and Sanger sequencing. Gene copy number variations of pfgch 1 were investigated using real-time polymerase chain reaction assay. Results Sequences of the pfdhfr and pfdhps genes were obtained from 96% (517/536) and 91% (486/536) of the samples, respectively. There were 59 distinct haplotypes, including single to octuple mutations. The two major haplotypes observed included IRN I- AGE AA (25%) and IRNL -S G K G A (19%). The sextuple mutation IRNL -S G K G A increased markedly over time in several study sites, including Pailin, Preah Vihear, Ratanakiri, and Ubon Ratchathani, whereas IRNI - AGE AA decreased over time in Preah Vihear, Champasak, and Ubon Ratchathani. Octuple mutations were first observed in west Cambodia in 2011 and subsequently in northeast Cambodia, as well as in southern Laos by 2018. Amplification of the pfgch1 gene increased over time across the region, particularly in northeast Thailand close to the border with Laos and Cambodia. Conclusion Despite the fact that SP therapy was discontinued in Thailand, Cambodia, and Laos decades ago, parasites retained the pfdhfr and pfdhps mutations. Numerous haplotypes were found to be prevalent among the parasites. Frequent monitoring of pfdhfr and pfdhps in these areas is required due to the relatively rapid evolution of mutation patterns." @default.
• W4311651314 created "2022-12-27" @default.
• W4311651314 creator A5000615940 @default.
• W4311651314 creator A5005391966 @default.
• W4311651314 creator A5011726781 @default.
• W4311651314 creator A5028227666 @default.
• W4311651314 creator A5030088781 @default.
• W4311651314 creator A5034097318 @default.
• W4311651314 creator A5046547648 @default.
• W4311651314 creator A5048691393 @default.
• W4311651314 creator A5051408897 @default.
• W4311651314 creator A5057353028 @default.
• W4311651314 creator A5059054043 @default.
• W4311651314 creator A5060413929 @default.
• W4311651314 creator A5063685504 @default.
• W4311651314 creator A5077610184 @default.
• W4311651314 creator A5082305936 @default.
• W4311651314 creator A5082756487 @default.
• W4311651314 creator A5088625217 @default.
• W4311651314 date "2022-12-16" @default.
• W4311651314 modified "2023-10-01" @default.
• W4311651314 title "Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries" @default.
• W4311651314 cites W1971635729 @default.
• W4311651314 cites W1975997448 @default.
• W4311651314 cites W1976176203 @default.
• W4311651314 cites W1976416379 @default.
• W4311651314 cites W1990296740 @default.
• W4311651314 cites W1993408219 @default.
• W4311651314 cites W2005705112 @default.
• W4311651314 cites W2010272823 @default.
• W4311651314 cites W2026745106 @default.
• W4311651314 cites W2030811282 @default.
• W4311651314 cites W2031154281 @default.
• W4311651314 cites W2033974277 @default.
• W4311651314 cites W2038945865 @default.
• W4311651314 cites W2047009134 @default.
• W4311651314 cites W2070239562 @default.
• W4311651314 cites W2076086908 @default.
• W4311651314 cites W2079451231 @default.
• W4311651314 cites W2081729133 @default.
• W4311651314 cites W2086603421 @default.
• W4311651314 cites W2099198335 @default.
• W4311651314 cites W2106576615 @default.
• W4311651314 cites W2109901137 @default.
• W4311651314 cites W2125629663 @default.
• W4311651314 cites W2132923209 @default.
• W4311651314 cites W2137764200 @default.
• W4311651314 cites W2159524000 @default.
• W4311651314 cites W2162881343 @default.
• W4311651314 cites W2165338002 @default.
• W4311651314 cites W2167179150 @default.
• W4311651314 cites W2167296967 @default.
• W4311651314 cites W2169195671 @default.
• W4311651314 cites W2187324237 @default.
• W4311651314 cites W2274136429 @default.
• W4311651314 cites W2279630534 @default.
• W4311651314 cites W2405750975 @default.
• W4311651314 cites W3011990934 @default.
• W4311651314 cites W3140170335 @default.
• W4311651314 cites W622810663 @default.
• W4311651314 doi "https://doi.org/10.1371/journal.pone.0278928" @default.
• W4311651314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36525403" @default.
• W4311651314 hasPublicationYear "2022" @default.
• W4311651314 type Work @default.
• W4311651314 citedByCount "1" @default.
• W4311651314 countsByYear W43116513142023 @default.
• W4311651314 crossrefType "journal-article" @default.
• W4311651314 hasAuthorship W4311651314A5000615940 @default.
• W4311651314 hasAuthorship W4311651314A5005391966 @default.
• W4311651314 hasAuthorship W4311651314A5011726781 @default.
• W4311651314 hasAuthorship W4311651314A5028227666 @default.
• W4311651314 hasAuthorship W4311651314A5030088781 @default.
• W4311651314 hasAuthorship W4311651314A5034097318 @default.
• W4311651314 hasAuthorship W4311651314A5046547648 @default.
• W4311651314 hasAuthorship W4311651314A5048691393 @default.
• W4311651314 hasAuthorship W4311651314A5051408897 @default.
• W4311651314 hasAuthorship W4311651314A5057353028 @default.
• W4311651314 hasAuthorship W4311651314A5059054043 @default.
• W4311651314 hasAuthorship W4311651314A5060413929 @default.
• W4311651314 hasAuthorship W4311651314A5063685504 @default.
• W4311651314 hasAuthorship W4311651314A5077610184 @default.
• W4311651314 hasAuthorship W4311651314A5082305936 @default.
• W4311651314 hasAuthorship W4311651314A5082756487 @default.
• W4311651314 hasAuthorship W4311651314A5088625217 @default.
• W4311651314 hasBestOaLocation W43116513141 @default.
• W4311651314 hasConcept C104317684 @default.
• W4311651314 hasConcept C114851261 @default.
• W4311651314 hasConcept C135763542 @default.
• W4311651314 hasConcept C159047783 @default.
• W4311651314 hasConcept C197754878 @default.
• W4311651314 hasConcept C203014093 @default.
• W4311651314 hasConcept C2777035104 @default.
• W4311651314 hasConcept C2777234095 @default.
• W4311651314 hasConcept C2778048844 @default.
• W4311651314 hasConcept C2778301690 @default.
• W4311651314 hasConcept C2778371730 @default.
• W4311651314 hasConcept C2780441369 @default.
• W4311651314 hasConcept C54355233 @default.

• next